MINOXIDIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Minoxidil, and what generic alternatives are available?
Minoxidil is a drug marketed by Perrigo Pharma Intl, Par Pharm, Royce Labs, Sun Pharm Industries, Usl Pharma, Watson Labs, P And L, Taro, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb, Copley Pharm, Hikma, L Perrigo Co, Sight Pharms, Teva, Avacor Prods, Perrigo, and Perrigo New York. and is included in twenty-six NDAs.
The generic ingredient in MINOXIDIL is minoxidil. There are eight drug master file entries for this compound. Ninety-seven suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minoxidil
A generic version of MINOXIDIL was approved as minoxidil by WATSON LABS on March 3rd, 1987.
Summary for MINOXIDIL
US Patents: | 0 |
Applicants: | 19 |
NDAs: | 26 |
Finished Product Suppliers / Packagers: | 29 |
Raw Ingredient (Bulk) Api Vendors: | 150 |
Clinical Trials: | 57 |
Patent Applications: | 4,224 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MINOXIDIL |
DailyMed Link: | MINOXIDIL at DailyMed |
Recent Clinical Trials for MINOXIDIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Industrial Farmacéutica Cantabria, S.A. | Phase 3 |
Bioskin GmbH | Phase 3 |
BioClever 2005 S.L. | Phase 3 |
Pharmacology for MINOXIDIL
Drug Class | Arteriolar Vasodilator |
Physiological Effect | Arteriolar Vasodilation |
Medical Subject Heading (MeSH) Categories for MINOXIDIL
Anatomical Therapeutic Chemical (ATC) Classes for MINOXIDIL
Paragraph IV (Patent) Challenges for MINOXIDIL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
WOMEN'S ROGAINE | Topical Aerosol Foam | minoxidil | 5% | 021812 | 1 | 2015-02-04 |
WOMEN'S ROGAINE | Topical Aerosol Foam | minoxidil | 5% | 021812 | 1 | 2009-04-06 |